NDC 0404-9825

Brevibloc

Esmolol Hydrochloride

Brevibloc is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc. The primary component is Esmolol Hydrochloride.

Product ID0404-9825_891cf8da-b6d8-417b-a8dc-7863d6c01e4d
NDC0404-9825
Product TypeHuman Prescription Drug
Proprietary NameBrevibloc
Generic NameEsmolol Hydrochloride
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-01-09
Marketing CategoryNDA /
Application NumberNDA019386
Labeler NameHenry Schein, Inc
Substance NameESMOLOL HYDROCHLORIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesAdrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0404-9825-10

1 VIAL, SINGLE-DOSE in 1 BAG (0404-9825-10) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-01-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Brevibloc" or generic name "Esmolol Hydrochloride"

NDCBrand NameGeneric Name
0404-9825Breviblocesmolol hydrochloride
10019-055BreviblocEsmolol Hydrochloride
10019-075BreviblocEsmolol Hydrochloride
10019-115BreviblocEsmolol Hydrochloride
10019-666BREVIBLOCesmolol hydrochloride
10019-668BREVIBLOCesmolol hydrochloride
10019-672BREVIBLOCBREVIBLOC
10019-670BREVIBLOCBREVIBLOC
52584-115BreviblocBrevibloc
0404-9858ESMOLOL HYDROCHLORIDEESMOLOL HYDROCHLORIDE
0641-2965Esmolol HydrochlorideESMOLOL HYDROCHLORIDE
10019-120Esmolol HydrochlorideEsmolol Hydrochloride

Trademark Results [Brevibloc]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BREVIBLOC
BREVIBLOC
73433960 1287620 Live/Registered
American Hospital Supply Corporation
1983-07-08
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.